Fumarase deficiency: a new cause of mitochondrial encephalomyopathy - PubMed (original) (raw)
Case Reports
Fumarase deficiency: a new cause of mitochondrial encephalomyopathy
A B Zinn et al. N Engl J Med. 1986.
Abstract
We observed a deficiency of both the mitochondrial and cytosolic forms of fumarase in a male infant with mitochondrial encephalomyopathy who presented at one month of age with failure to thrive, developmental delay, hypotonia, cerebral atrophy, lactic and pyruvic acidemia, and fumaric aciduria. The patient died at eight months of age. Isolated skeletal-muscle mitochondria showed selective defects in the oxidation of glutamate (31 ng atoms of oxygen consumed per minute per milligram of mitochondrial protein, as compared with 94 +/- 19 [mean +/- SD] in five controls) and of succinate (18 vs. 145 +/- 18 ng atoms of oxygen per minute per milligram of protein), whereas isolated liver mitochondria oxidized these and other substrates normally. Fumarase activity was virtually absent in both liver mitochondria (53 vs. 2878 +/- 248 nmol per minute per milligram of protein [5 controls]) and skeletal-muscle mitochondria (23 vs. 1997 +/- 717 nmol per minute per milligram [12 controls]). Seventeen other mitochondrial enzymes had normal activity in both liver and muscle mitochondrial extracts. Fumarase activity was also significantly reduced in homogenates of liver tissue (less than 1 vs. 90 +/- 25 mumol per minute per gram of wet weight [five controls]) and skeletal muscle (less than 1 vs. 21 +/- 4 mumol per minute per gram [five controls]), indicating a deficiency of both mitochondrial and cytosolic fumarases. Organ differences in intramitochondrial accumulation of fumarate may have accounted for the selective oxidative defects observed in the skeletal-muscle mitochondria but not liver mitochondria. All these findings are consistent with a profound combined fumarase deficiency.
Similar articles
- Fumarase deficiency: two siblings with enlarged cerebral ventricles and polyhydramnios in utero.
Remes AM, Rantala H, Hiltunen JK, Leisti J, Ruokonen A. Remes AM, et al. Pediatrics. 1992 Apr;89(4 Pt 2):730-4. Pediatrics. 1992. PMID: 1557269 Review. - Comparison of populations of mRNA coding fumarase in rat brain and liver.
Hiraga K, Tuboi S. Hiraga K, et al. Biochem Int. 1985 Apr;10(4):681-7. Biochem Int. 1985. PMID: 4026873 - Fumarase deficiency is an autosomal recessive encephalopathy affecting both the mitochondrial and the cytosolic enzymes.
Gellera C, Uziel G, Rimoldi M, Zeviani M, Laverda A, Carrara F, DiDonato S. Gellera C, et al. Neurology. 1990 Mar;40(3 Pt 1):495-9. doi: 10.1212/wnl.40.3_part_1.495. Neurology. 1990. PMID: 2314594 - [Mitochondrial fumarase].
Matsuda J, Kuroda Y. Matsuda J, et al. Nihon Rinsho. 2002 Apr;60 Suppl 4:126-9. Nihon Rinsho. 2002. PMID: 12013833 Review. Japanese. No abstract available.
Cited by
- Fumaric aciduria: an overview and the first Brazilian case report.
Allegri G, Fernandes MJ, Scalco FB, Correia P, Simoni RE, Llerena JC Jr, de Oliveira ML. Allegri G, et al. J Inherit Metab Dis. 2010 Aug;33(4):411-9. doi: 10.1007/s10545-010-9134-2. Epub 2010 Jun 15. J Inherit Metab Dis. 2010. PMID: 20549362 Review. - Biochemical diagnosis of mitochondrial disorders.
Rodenburg RJ. Rodenburg RJ. J Inherit Metab Dis. 2011 Apr;34(2):283-92. doi: 10.1007/s10545-010-9081-y. Epub 2010 May 4. J Inherit Metab Dis. 2011. PMID: 20440652 Free PMC article. Review. - A novel nonsense mutation in the fumarate hydratase gene in a Chinese patient with recurrent leiomyomas.
Ruan Y, Feng W, Yang C. Ruan Y, et al. F S Rep. 2023 Aug 25;4(4):410-415. doi: 10.1016/j.xfre.2023.08.007. eCollection 2023 Dec. F S Rep. 2023. PMID: 38204953 Free PMC article. - Genetics of enzymatic dysfunctions in metabolic disorders and cancer.
Mahé M, Rios-Fuller TJ, Karolin A, Schneider RJ. Mahé M, et al. Front Oncol. 2023 Aug 2;13:1230934. doi: 10.3389/fonc.2023.1230934. eCollection 2023. Front Oncol. 2023. PMID: 37601653 Free PMC article. Review. - Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency.
Bourgeron T, Chretien D, Poggi-Bach J, Doonan S, Rabier D, Letouzé P, Munnich A, Rötig A, Landrieu P, Rustin P. Bourgeron T, et al. J Clin Invest. 1994 Jun;93(6):2514-8. doi: 10.1172/JCI117261. J Clin Invest. 1994. PMID: 8200987 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical